A budget impact analysis of the introduction of erythropoiesis stimulating agent subsequent entry biologics for the treatment of anemia of chronic kidney disease in Canada

Overview of attention for article published in Canadian Journal of Kidney Health and Disease, November 2014

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (83rd percentile)
Above-average Attention Score compared to outputs of the same age and source (60th percentile)

Mentioned by

blogs: 1 blog

twitter: 1 X user

Citations

dimensions_citation: 4 Dimensions

Readers on

mendeley: 33 Mendeley

Summary Blogs X Dimensions citations

So far, Altmetric has seen 1 blog post.

Regulators grapple with Canada’s first generic biologic drug

Healthy Debate, 08 Jan 2015

Biologic drugs have revolutionized treatments for diseases from cancer to multiple sclerosis. But because they’re developed out…

This page shows the most recent blog posts that mention this research output.

Click here to find out how to access more activity.